FORM C |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB APPROVAL |
| OMB Number: ####-#### Estimated average burden hours per response: ##.# |
Form C: Filer Information
Filer CIK: | 0001957114 |
Filer CCC: | XXXXXXXX |
Period: | 12-31-2022 |
Is this a LIVE or TEST Filing? | ![]() ![]() |
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption? | ![]() |
Would you like a Return Copy? | ![]() |
Submission Contact Information
Name: | |
Phone Number: | |
Contact E-Mail Address: | |
Notify via Filing Website only? | ![]() |
Form C: Issuer Information
Issuer Information
Name of Issuer: | iMetabolic Biopharma Corporation |
Legal Status of Issuer:
Form: | Corporation |
Jurisdiction of Incorporation/Organization: |
NEVADA
|
Date of Incorporation/Organization: | 11-17-2017 |
Physical Address of Issuer:
Address 1: | 2155 E Conference Dr STE 115 |
City: | Tempe |
State/Country: |
ARIZONA
|
Mailing Zip/Postal Code: | 85284-2604 |
Website of Issuer: | https://imbiopharma.com/ |
Form C: Annual Report Disclosure Requirements
Annual Report Disclosure Requirements
Current Number of Employees: | 4 |
Total Assets Most Recent Fiscal Year-end: | 4601.00 |
Total Assets Prior Fiscal Year-end: | 64248.00 |
Cash and Cash Equivalents Most Recent Fiscal Year-end: | 4601.00 |
Cash and Cash Equivalents Prior Fiscal Year-end: | 62248.00 |
Accounts Receivable Most Recent Fiscal Year-end: | 0.00 |
Accounts Receivable Prior Fiscal Year-end: | 0.00 |
Short-term Debt Most Recent Fiscal Year-end: | 0.00 |
Short-term Debt Prior Fiscal Year-end: | 0.00 |
Long-term Debt Most Recent Fiscal Year-end: | 161025.00 |
Long-term Debt Prior Fiscal Year-end: | 155471.00 |
Revenue/Sales Most Recent Fiscal Year-end: | 0.00 |
Revenue/Sales Prior Fiscal Year-end: | 0.00 |
Cost of Goods Sold Most Recent Fiscal Year-end: | 0.00 |
Cost of Goods Sold Prior Fiscal Year-end: | 0.00 |
Taxes Paid Most Recent Fiscal Year-end: | 0.00 |
Taxes Paid Prior Fiscal Year-end: | 0.00 |
Net Income Most Recent Fiscal Year-end: | -94513.00 |
Net Income Prior Fiscal Year-end: | -63745.00 |
Form C: Signature
Signature
Issuer: | iMetabolic Biopharma Corporation |
Signature: | Urban Austin Kiernan |
Title: | Chairman, President, Treasurer and Principle Financial Officer |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Urban Austin Kiernan |
Title: | Chairman, President, Treasurer and Principle Financial Officer |
Date: | 04-26-2023 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Jeffrey D. Zimmerman |
Title: | Secretary and General Counsel |
Date: | 04-26-2023 |